Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS. (2015)

First Author: Streeter HB
Attributed to:  Targeting GSK-3 in antigen-specific immunotherapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1212/nxi.0000000000000093

PubMed Identifier: 25798453

Publication URI: http://europepmc.org/abstract/MED/25798453

Type: Journal Article/Review

Volume: 2

Parent Publication: Neurology(R) neuroimmunology & neuroinflammation

Issue: 3

ISSN: 2332-7812